November 26, 2025 · Form 4 insider transaction
Kramer Kelly A. sold 2,806 shares of Gilead Sciences, Inc. at $127.11 per share, a transaction worth $356.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 5 days after the transaction.
The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 27, 2025.